Editorial commentary: getting smart in how we pay for HCV drugs: KAOS vs CONTROL.

Academic Article

Published In

Keywords

  • HCV, cost, cost-effectiveness, pharmacy benefit managers, therapy, Antiviral Agents, Female, Hepatitis C, Chronic, Humans, Male
  • Digital Object Identifier (doi)

    Author List

  • Saag MS
  • Start Page

  • 169
  • End Page

  • 170
  • Volume

  • 61
  • Issue

  • 2